Temasek’s SeaTown to invest up to S$115 million in Singapore healthcare firm AddVita
Investment brings alternative investor close to full deployment of its US$1 billion-plus private capital fund
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[SINGAPORE] SeaTown Holdings, an investment manager indirectly owned by Temasek, said on Wednesday (May 21) it is committing up to S$115 million in Singapore healthcare and life sciences firm AddVita.
Offering medical and laboratory technologies, AddVita sells pharmaceutical products as well, to hospitals, clinics, pharmacies and healthcare providers throughout Asia, particularly South-east Asia.
It also buys companies, focusing on small and medium-sized distributors in the healthcare and life sciences sectors, using the so-called buy-and-build strategy.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025
